How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,237 results for

ADHD Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)

Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You (...) have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03325894

2017 Clinical Trials

82. Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years

Disorder (ADHD) Actual Study Start Date : November 17, 2017 Actual Primary Completion Date : June 7, 2018 Actual Study Completion Date : June 7, 2018 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: SHP465 Participants will be randomized to receive SHP465 capsule 6.25 milligram (mg) orally once daily for 4 weeks. Drug: SHP465 SHP465 capsule 6.25 mg orally once daily for 4 weeks Placebo Comparator: Placebo (...) Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study

2017 Clinical Trials

83. Experimental fMRI Study of Guanfacine and Lisdexamfetamine in ADHD Adolescents

Experimental fMRI Study of Guanfacine and Lisdexamfetamine in ADHD Adolescents Experimental fMRI Study of Guanfacine and Lisdexamfetamine in ADHD Adolescents - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Experimental fMRI Study of Guanfacine and Lisdexamfetamine in ADHD Adolescents (AGUALIS) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03333668 Recruitment Status : Not yet recruiting First Posted : November 7, 2017 Last

2017 Clinical Trials

84. Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism

Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove (...) one or more studies before adding more. Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03337646 Recruitment Status

2017 Clinical Trials

85. Psychoeducational Groups for Adults With ADHD

Completion Date : June 15, 2019 Estimated Study Completion Date : December 15, 2019 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: psychoeducational groups Psychoeducational group therapy and standard treatment (ADHD treatment as usual) Behavioral: Psychoeducational group therapy The group-based psychoeducational program consists of 10 sessions, run over 10 consecutive weeks. Each session consist (...) Psychoeducational Groups for Adults With ADHD Psychoeducational Groups for Adults With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Psychoeducational Groups for Adults With ADHD The safety

2017 Clinical Trials

86. Impact of Combined Medication and Behavioral Treatment for ASD & ADHD

Provider, Investigator, Outcomes Assessor) Primary Purpose: Treatment Official Title: Impact of Combined Medication and Behavioral Treatment in Young Children With Comorbid ASD and ADHD Actual Study Start Date : May 30, 2018 Estimated Primary Completion Date : July 2021 Estimated Study Completion Date : July 2021 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: P-ESDM + Amphetamine (...) Impact of Combined Medication and Behavioral Treatment for ASD & ADHD Impact of Combined Medication and Behavioral Treatment for ASD & ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Impact of Combined

2017 Clinical Trials

87. KP415 Classroom Study in Children (6-12 Years of Age) With ADHD

KP415 Classroom Study in Children (6-12 Years of Age) With ADHD KP415 Classroom Study in Children (6-12 Years of Age) With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. KP415 Classroom Study (...) in Children (6-12 Years of Age) With ADHD The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03292952 Recruitment Status : Completed First Posted : September 26, 2017 Last Update Posted : June 14, 2018 Sponsor: KemPharm, Inc. Information provided by (Responsible Party): KemPharm, Inc. Study Details Study

2017 Clinical Trials

88. Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)

Diagnosed With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD) Actual Study Start Date : November 30, 2016 Estimated Primary Completion Date : December 31, 2018 Estimated Study Completion Date : December 31, 2018 Resource links provided by the National Library of Medicine related topics: related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Intervention Each child participant in the Intervention group will be taking 4 capsules of Vayarin (...) Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD) Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2017 Clinical Trials

89. Psychiatric Assessment Of Parents Of Children With ADHD

Assessment Of Parents Of Children With Attention Deficit Hyperactivity Disorder Estimated Study Start Date : November 2017 Estimated Primary Completion Date : November 2018 Estimated Study Completion Date : November 2019 Resource links provided by the National Library of Medicine related topics: Groups and Cohorts Go to Group/Cohort Parents of children with ADHD 100 parents of 50 children who were diagnosed with ADHD and Parent of children without ADHD 100 parents of 50 children who are ADHD free (...) Psychiatric Assessment Of Parents Of Children With ADHD Psychiatric Assessment Of Parents Of Children With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Psychiatric Assessment Of Parents Of Children

2017 Clinical Trials

90. Evaluation of a Parent/Child Cognitive-Behaviorial Therapy Program in ADHD Children With Emotional Dysregulation Profile

Evaluation of a Parent/Child Cognitive-Behaviorial Therapy Program in ADHD Children With Emotional Dysregulation Profile Evaluation of a Parent/Child Cognitive-Behaviorial Therapy Program in ADHD Children With Emotional Dysregulation Profile - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. Evaluation of a Parent/Child Cognitive-Behaviorial Therapy Program in ADHD Children With Emotional Dysregulation Profile (DP-KID) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our

2017 Clinical Trials

91. Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD

, double-blind, placebo-controlled study design. Masking: Double (Participant, Investigator) Primary Purpose: Treatment Official Title: Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Study of Stimulant-induced Dopamine Release Using [11C]-Raclopride PET in Healthy Humans Actual Study Start Date : August 15, 2017 Estimated Primary Completion Date : January 2022 Estimated Study Completion Date : January 2022 Resource links provided by the National Library (...) Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Vitamin D

2017 Clinical Trials

92. Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response

Enrollment : 60 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response Actual Study Start Date : July 1, 2018 Estimated Primary Completion Date : July 1, 2020 Estimated Study Completion Date : December 1, 2020 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm (...) Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding

2017 Clinical Trials

93. Prevalence and correlates of ADHD among adolescents in a Beirut community sample: results from the BEI-PSY Study (PubMed)

Prevalence and correlates of ADHD among adolescents in a Beirut community sample: results from the BEI-PSY Study This study aims to investigate the prevalence, correlates and treatment seeking behavior related to ADHD among adolescents from Lebanon.Five hundred and ten adolescents were recruited through multistage stratified cluster sampling of households in Beirut, and separately interviewed along with one parent/legal guardian, using the DAWBA. All adolescents completed the PRQ and the SDQ (...) ; the parent/legal guardian also completed the SDQ and provided basic demographic information, including attitudes towards seeking mental health services.10.20% of the adolescents were diagnosed with ADHD. Having ADHD was associated with having academic difficulties and being involved in bullying. Adolescents with ADHD also had higher odds of drinking alcohol, smoking cigarettes, and having comorbid emotional and conduct disorders (compared to those without ADHD). Adolescents with ADHD and their parents

Full Text available with Trip Pro

2017 Child and adolescent psychiatry and mental health

94. Italian regional health service costs for diagnosis and 1-year treatment of ADHD in children and adolescents (PubMed)

, continuing efforts are need to define costs and resources to guarantee appropriate care, also for ADHD. (...) Italian regional health service costs for diagnosis and 1-year treatment of ADHD in children and adolescents The main aim of this study was to estimate the costs associated with diagnostic assessment and 1-year therapy in children and adolescents enrolled in 18 ADHD reference centres. Data concerning 1887 children and adolescents from the mandatory ADHD registry database during the 2012-2014 period were analysed. The overall diagnostic and treatment costs per patient amounts to €574 and €830

Full Text available with Trip Pro

2017 International journal of mental health systems

95. Neuronal Intra-Individual Variability Masks Response Selection Differences between ADHD Subtypes—A Need to Change Perspectives (PubMed)

-C seemed to employ more cognitive resources overall. These differences are reflected in inferior parietal areas. The study demonstrates differences in neuronal mechanisms related to response selection processes between ADD and ADHD-C which, according to source localization, arise from the inferior parietal cortex. Importantly, these differences could only be detected when accounting for intra-individual variability. The results imply that it is very likely that differences in neurophysiological (...) Neuronal Intra-Individual Variability Masks Response Selection Differences between ADHD Subtypes—A Need to Change Perspectives Due to the high intra-individual variability in attention deficit/hyperactivity disorder (ADHD), there may be considerable bias in knowledge about altered neurophysiological processes underlying executive dysfunctions in patients with different ADHD subtypes. When aiming to establish dimensional cognitive-neurophysiological constructs representing symptoms of ADHD

Full Text available with Trip Pro

2017 Frontiers in human neuroscience

96. Comparative Cost Analysis of Sequential, Adaptive, Behavioral, Pharmacological, and Combined Treatments for Childhood ADHD. (PubMed)

Comparative Cost Analysis of Sequential, Adaptive, Behavioral, Pharmacological, and Combined Treatments for Childhood ADHD. We conducted a cost analysis of the behavioral, pharmacological, and combined interventions employed in a sequential, multiple assignment, randomized, and adaptive trial investigating the sequencing and enhancement of treatment for children with attention deficit hyperactivity disorder (ADHD; Pelham et al., 201X; N = 146, 76% male, 80% Caucasian). The quantity of resources (...) ) found equivalent or superior outcomes for treatments beginning with low-intensity behavior modification compared to intervention beginning with medication. Combined with the present analyses, these findings suggest that initiating treatment with behavior modification rather than medication is the more cost-effective option for children with ADHD.

Full Text available with Trip Pro

2017 Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53 Controlled trial quality: uncertain

97. Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine (PubMed)

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine To describe the characteristics and medication treatment patterns of adult patients with attention-deficit/hyperactivity disorder (ADHD) prescribed atomoxetine in Japan.A retrospective analysis of insurance claims data was conducted using the Japan Medical Data Center database. Adults (≥18 years) with ADHD who had ≥1 atomoxetine claim from (...) % of patients were male. Nearly 72.0% of the patients had at least one comorbid mental health condition in the baseline period; depression (43.8%) and insomnia (40.7%) were the most common mental health comorbidities. Most common physical comorbidities were chronic obstructive pulmonary disease (14.4%) and diabetes (12.9%). Non-ADHD-specific psychotropics were prescribed to 59.7% of patients during the baseline period and to 65.9% during the follow-up period; 6.6% were prescribed non-ADHD-specific

Full Text available with Trip Pro

2018 Neuropsychiatric disease and treatment

98. ERP Correlates of Proactive and Reactive Cognitive Control in Treatment-Naïve Adult ADHD (PubMed)

critical measures, Cue P3, late CNV, and NoGo N2, there were no significant differences between the groups. This indicated normal preparatory processes and conflict monitoring in ADHD patients. However, the patients had attenuated Go P3 and NoGoP3 amplitudes relative to controls, suggesting reduced allocation of attentional resources to processes involved in response control. The patients also had a higher rate of Go signal omission errors, but no other performance decrements compared with controls (...) . Reduced Go P3 and NoGo P3 amplitudes were associated with poorer task performance, particularly in the ADHD group. Notably, the ERPs were not associated with self-reported mood or anxiety. The results provide electrophysiological evidence for reduced effortful engagement of attentional resources to both Go and NoGo signals when reactive response control is needed. The absence of group differences in ERP components indexing proactive control points to impairments in specific aspects of cognitive

Full Text available with Trip Pro

2016 PloS one

99. The neuronal mechanisms underlying improvement of impulsivity in ADHD by theta/beta neurofeedback (PubMed)

, attentional selection and resource allocation processes were not affected by neurofeedback. Rather, neurofeedback effects seem to be based on the modulation of response inhibition processes in medial frontal cortices. The study shows that specific neuronal mechanisms underlying impulsivity are modulated by theta/beta neurofeedback in ADHD. The applied neurofeedback protocol could be particularly suitable to address inhibitory control. The study validates assumed functional neuroanatomical target regions (...) The neuronal mechanisms underlying improvement of impulsivity in ADHD by theta/beta neurofeedback Neurofeedback is increasingly recognized as an intervention to treat core symptoms of attention deficit hyperactivity disorder (ADHD). Despite the large number of studies having been carried out to evaluate its effectiveness, it is widely elusive what neuronal mechanisms related to the core symptoms of ADHD are modulated by neurofeedback. 19 children with ADHD undergoing 8 weeks of theta/beta

Full Text available with Trip Pro

2016 Scientific reports

100. A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD

Title: A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) Study Start Date : February 2016 Actual Primary Completion Date : January 6, 2017 Actual Study Completion Date : January 6, 2017 Resource links provided by the National Library of Medicine related topics: Groups and Cohorts Go to Outcome Measures Go to Primary Outcome Measures : Presence of mGluR network mutations [ Time Frame: At study enrollment (...) A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2016 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>